| Produktlista | ||
| API och mellanprodukter | ||
| produktnamn | CAS-nr. | Ansökan |
| 2-metylindolin | 6872-06-6 | Indapamids mellanprodukt |
| 1-amino-2-metylindolinhydroklorid | 102789-79-7 | |
| 4-klor-3-sulfamoylbensoesyra | 1205-30-7 | |
| 4-klor-3-sulfamoylbensoylklorid | 70049-77-3 | |
| 1-(3-metoxifenyl)piperazin | 16015-71-7 | Letermovirs mellanliggande |
| 1-(3-metoxifenyl)piperazin-dihydroklorid | 6968-76-9 | |
| 2-broMo-6-fluorbensenamin | 65896-11-9 | |
| (2-metoxi-5-(trifluormetyl)anilin) | 349-65-5 | |
| 2-propensyra, 3-(2-amino-3-fluorfenyl)-, metylester, (2E)- | 690664-20-1 | |
| 4-kinazolinättiksyra,8-fluoro-1,2,3,4-tetrahydro-3-[2-metoxi-5-(trifluormetyl)fenyl]-2-oxo-, metylester | 917389-21-0 | |
| 2-propensyra, 3-[3-fluor-2-[(fenoxikarbonyl)amino]fenyl]-, metylester, (2E)- | 1791412-01-5 | |
| 1-metylindol | 603-76-9 | AZD9291(Osimertinib)s mellanprodukt |
| N,N,N'-trimetyletylendiamin | 142-25-6 | |
| 3-(2-klorpyrimidin-4-yl)-l-metylindol | 1032452-86-0 | |
| 4-fluor-2-metoxi-5-nitroanilin | 1075705-01-9 | |
| 1-(1-etoxietyl)-4-(4,4,5,5-tetrametyl-1,3,2 -dioxaborolan-2-yl)-lH-pyrazol | 1029716-44-6 | Ruxolitinibs intermediär |
| 4-klor-7H-pyrrolo[2,3-d]pyrimidin | 3680-69-1 | |
| 3-cyklopentylakrylnitril | 591769-05-0 | |
| Cyklopentankarbaldehyd | 872-53-7 | |
| 2-amino-3,5-dibrompyrazin | 24241-18-7 | Upadacitinibs mellanliggande |
| 1,1-cyklopentandiättiksyra | 16713-66-9 | |
| 3,3-tetrametyleneglutarimid | 1075-89-4 | Buspiron är mellanliggande |
| 1-(2-pyrimidinyl)piperazin | 20980-22-7 | |
| 5-metyl-1,3,4-oxadiazol-2-karboxylsyra kaliumsalt | 888504-28-7 | Raltegravirs mellanprodukt |
| metyl 2-[1-[[(bensyloxi)karbonyl]amino]-1-metyletyl]-5,6-dihydroxipyrimidin-4-karboxylat | 519032-08-7 | |
| 5-metyl-2(lH)-pyridinon | 1003-68-5 | Pirfenidones intermediär |
| ((3aR,4R,6R,6aR)-6-(4-(hydroxiamino)-2-oxopyrimidin-1(2H)-yl)-2,2-dimetyltetrahydrofuro[3,4-d][1,3]dioxol -4-yl)metylisobutyrat | 2346620-55-9 | Molnupiravirs mellanprodukt |
| 1-brom-3-metyl-2-buten | 870-63-3 | Sofalcones mellanliggande |
| Tianeptin natriumsalt | 30123-17-2 | Antidepression är mellanliggande |
| 7-metoxi-1-tetralon | 6836-19-7 | Agomelatins mellanliggande |
| 4-(4-broMo-3-(hydroximetyl)fenoxi)bensonitril | 906673-45-8 | Crisaboroles mellanliggande |
| Metyl-4,6-diklorpyridazin-3-karboxylat | 372118-01-9 | Deucravacitinibs intermediär |
| 4-kloropyrrolo[2,3-d]pyrimidin | 3680-69-1 | tofacitinib, Ruxolitinibs intermediär |
| (R)-(+)-2-tetrahydrofuronsyra | 87392-05-0 | Faroenems mellanliggande |
| Metyl-4-klor-4-oxobutanoat | 1490-25-1 | Mellanliggande |
| 2,5,6-tetraklorpyridin | 54718-39-7 | |
| p-tolylhydrazinhydroklorid | 637-60-5 | |
| Fenylhydrazinhydroklorid | 59-88-1 | |
| Kokarboxylas | 154-87-0 | |
| 1-brom-4-jodbensen | 589-87-7 | |
| 4-jodonitrobensen | 636-98-6 | |
| 2-acetyl-4-metylpyridin | 59576-26-0 | Alpelisib Intermediates |
| 1,1,1-trifluoro-2-(4-metylpyridin-2-yl)propanol | 1396893-43-8 | Alpelisib Intermediates |
| 4-metyl-2-(1,1,1-trifluoro-2-dimetyl-2-etyl)pyridin | 1378865-93-0 | Alpelisib Intermediates |
| 4-kloropyrrolidin | 3680-69-1 | Tofacitinib Intermediärer |
| 1,4-klor-7-p-toluensulfonyl-7H-pyrrolo[2,3-d]pyrimidin | 479633-63-1 | Tofacitinib Intermediärer |
| (3R, 4R)-l-bensyl-3-(metylamino)-4-metylpiperidin-dihydroklorid;Cis 1-bensyl-4-metyl-3-metylaminopiperidin-dihydroklorid | 1062580-52-2 | Tofacitinib Intermediärer |
| (2R, 3R)-2,3-bis[(4-metylbensoyl)oxi]bärnstenssyra och (3R,4R)-N,4-dimetyl-1-(fenylmetyl)-3-piperidinamin | 477600-71-8 | Tofacitinib Intermediärer |
| Fumaratvorolazan | 1260141-27-2 | Vonolasan mellanliggande |
| 2-(2-(2-fluorbensen)-2-oxietyl)propiononitril | 312307-38-3 | |
| 2-klor-5-(2-fluorfenyl)-1H-pyrrol-3-acetonitril | 1240948-72-4 | |
| 5-(2-fluorfenyl)-1H-pyrrol-3-acetonitril | 1240948-77-9 | |
| 5-(2-fluorfenyl)pyrrol-3-formaldehyd | 881674-56-2 | |
| 5-(2-fluorfenyl)-1-[(pyridin-3-yl)sulfonyl]-1H-pyrrol-3-formaldehyd | 881677-11-8 | |
| 5-(2-fluorfenyl)-N-metyl-1-(3-pyridylsulfonyl)-1H-pyrrol-3-metylamin | 881681-00-1 | |
| Pyridin-3-sulfonylklorid | 16133-25-8 | |
| tiolakton | 28092-52-6 | |
| Porfyrin E6 | 19660-77-6 | |
| (S)-(+)-2,2-dimetyl-1,3-dioxocyklopent-4-metylbensensulfonat | 23735-43-5 | |
| Biluvadin pentapeptid | 1450625-21-4 | Biluvadine pentapeptid intermediär |
| 3-klorfenylaceton | 936-59-4 | Mellanprodukt av dapoxetin |
| 1-[3-(acetoxi)fenyl]-2-brometanon | 38396-89-3 | |
| 10-(2-klorpyrimidin-4-yl)-6,7,8,9-tetrahydropyridino[1,2-a]indol | 2035090-53-8 | |
| 6-brom-8-klor-3,4-dihydronaftalen-2 (1H) - en | 1337847-33-2 | |
| Etylklorfluoracetat | 401-56-9 | |
| 2-klorbensimidazol | 4857--6--1 | |
| 6-brom-8-fluor-3,4-dihydronaftalen-2 (1H) - en | 1337857-08-5 | |
| N-acetyl-3-(3,5-difluorfenyl)-DL-alanin | 266360-52-5 | |
| 4-(metoxikarbonyl)-alfa-2-propargyl-fenylacetat metylester | 146464-90-6 | |
| 2-merkaptopyridin | 2637-34-5 | |
| 3-merkaptopyridin | 109-00-2 | |
| 3,5-dimetyl-2-pyrrolaldehyd | 2199-58-8 | |
| 3,5-dimetyl-4-nitropyrrol-2-formaldehyd | 40236-20-2 | |
| (3S)-3-[4-[(2-klor-5-jodfenyl)metyl]fenoxi]tetrahydrofuran | 915095-94-2 | |
| 4-Cyano-2-metoxibensaldehyd | 21962-45-8 | |
| 4-amino-5-metyl-2-hydroxipyridin | 95306-64-2 | |
| 17-amino-10-oxi-3,6,12,15-tetraoxa-9-azaheptadekansyra | 1143516-05-5 | |
| L-prolin tert-butylester | 2812-46-6 | |
| S-3-aminokinincykloaminhydroklorid | 119904-90-4 | Mellanprodukt av Palonosetron |
| (S) - 1,2,3,4-tetrahydro-l-naftosyra | 85977-52-2 | |
| 5,6,7,8-tetrahydro-l-naftosyra | 4242-18-6 | |
| Natriumbisulfitlösning | 7631-90-5 | Reduktionsmedel, konserveringsmedel, avfärgningsmedel, desinficeringsmedel. |
| Cyklopentanon | 120-92-3 | fotografiskt material, Medicin och parfymindustrin |
| 2-Adamantanon | 700-58-3 | fotografiskt material, farmaceutisk mellanprodukt. |
| 2-metylindol | 95-20-5 | Mellanliggande |
| 2,3,3-trimetylindolenin | 1640-39-7 | |
| 2,3,3,5-tetrametylindolenin | 25981-82-2 | |
| 2,5-dimetylindol | 1196-79-8 | |
| 1,2-dimetylindol | 875-79-6 | |
| Indol-3-karbinol | 700-06-1 | |
| Indol-3-karboxaldehyd | 487-89-8 | |
| Cyklopentylpropionylklorid | 104-97-2 | LCD-material. |
| 4-metoximetyl-2,3,5,6-tetrafluorbensylalkohol | 83282-91-1 | Bekämpningsmedels mellanprodukt |
| 7ACF | 80370-59-8 | |
| 7-ACQ | 103122-02-7 | |
| Bromacetonitril | 590-17-0 | paxlovid Intermediate |
| 2-fluor-3-(trifluormetyl)bensoesyra | 115029-22-6 | |
| 4,4-dimetoxi-2-butanon | 5436-21-5 | intermediär för pharma/agri-chem |
| 2-klorpyridin-3-sulfonylklorid | 6684-06-6 | |
| P-hydroxitiobensamid | 25984-63-8 | Febuxostat Intermediate |
| 2-Cyanoisonikotinsyra-metylester | 94413-64-6 | Topiroxostat Intermediär |
| 3,4-dimetoxi-2-metylpyridin-N-oxid | 72830-07-0 | Pantoprazol Intermediär |
| 2-amino-6-brompyridin | 19798-81-3 | Filgotinib Intermediate |
| Metyl-2-metoxi-4-aminobensoat | 27492-84-8 | Lenvatinib Intermediär |
| Cyklopropanacetonitril | 6542-60-5 | |
| Cyklopropan ättiksyra | 5239-82-7 | |
| Butylfosfatanhydrid | 163755-62-2 | Substitution av propylfosfatanhydrid |
| A-amino-2,4-difluorfenylättiksyra | 240409-02-3 | Fexuprazan Intermediate |
| 2-Cyanoisonikotinsyra | 161233-97-2 | Topiroxostat Intermediär |
| 2-Cyano-3-fluorpyridin✱ | 97509-75-6 | |
| Trimetylcyanosilan | 7677-24-9 | batterielektrolyt |
| 2-cyano-5-brompyridin | 97483-77-7 | tedizolid Intermediär |
| 3-Bromopyridin | 626-55-1 | |
| 3-brom-4-nitropyridin | 89364-04-5 | |
| 2-amino-5-brompyridin | 1072-97-5 | Palbociclib Intermediate |
| 2.3.5-trimetyl-4-nitropyridin-N-oxid | 86604-79-7 | Omeprazol Intermediate |
| 3,5-bis(trifluormetyl)tiobensamid | 317319-15-6 | |
| 3,5-bistrifluormetylbensonitril | 27126-93-8 | |
| 3-(3,5-bis(trifluormetyl)fenyl)-1H-1,2,4-triazol | 1333154-10-1 | Selinexor Intermediate |
| (Z)-3-(3-(3,5-bis(trifluormetyl)fenyl)-lH-1,2,4-triazol-1-yl)isopropylakrylat | 1333152-22-9 | |
| KPT-330 mellanliggande | 1388842-44-1 | |
| Saliniso | 1393477-72-9 | |
| 4-amino-5-metyl-2-hydroxipyridin | 95306-64-2 | Finerenone Intermediate |
| Etyl-2-cyanoacetat | 65193-87-5 | |
| 4-kloropyrrolidin | 3680-69-1 | Abrocitinib |
| 3-oxocyklobutanylkarboxylsyra | 23761-23-1 | Atopisk dermatit |
| 2-nitro-5-brompyridin | 39856-50-3 | Palbociclib |
| 2-nitro-5-klorpyridin | 52092-47-4 | |
| 6-nitro-lH-indazol | 7597-18-4 | 319460-85-0 Axitinib Intermediate |
| 6-amino-lH-indazol | 6967-12-0 | |
| 6-jod-lH-indazol | 261953-36-0 | |
| 3-jod-6-nitro-lH-indazol | 70315-70-7 | |
| 2,2'-ditiobis[N-metylbensamid] | 2527-58-4 | |
| 2-merkapto-N-metylbensamid | 20054-45-9 | |
| 3-jod-6-nitro-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol | 886230-74-6 | |
| (E)-6-nitro-3-[2-(pyridin-2-yl)etenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol | 886230-75-7 | |
| (E)-3-[2-(Pyridin-2-yl)etenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-amin | 886230-76-8 | |
| (E)-6-jod-3-[2-(pyridin-2-yl)etenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol | 886230-77-9 | |
| 2-[(3-jod-lH-indazol-6-yl)tio]-N-metylbensamid | 885126-34-1 | |
| N-metyl-2-[[3-[(1E)-2-(2-pyridinyl)etenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-yl]tio]bensamid | 885126-35-2 | |
| 2-acetyl-4-klortiofen | 34730-20-6 | 677007-74-8 Avatrombopagmaleat Intermediär |
| 4-(4-klor-2-tienyl)-2-tiazolamin | 570407-10-2 | |
| 1-cyklohexylpiperazin | 17766-28-8 | |
| 5,6-diklornikotinsyra | 41667-95-2 | |
| 5-klor-6-[4-(etoxikarbonyl)piperidino]-nikotinsyra | 931395-73-2 | |
| 4-(4-klortiofen-2-yl)-5-(4-cyklohexylpiperazin-1-yl)tiazol-2-amin | 570407-42-0 | |
| 5,6-diklor-n-[4-(4-klortiofen-2-yl)-5-(4-cyklohexylpiperazin-1-yl)tiazol-2-yl]nikotinamid | 570403-04-2 | |
| 5,6-diklor-N-(4-(4-klortiofen-2-yl)-5-(4-cyklohexylpiperazin-1-yl)tiazol-2-yl)nikotinamid | 570403-14-4 | |
| Avatrombopag Base | 570406-98-3 | |
| Etyl-2-cyanoacetoacetat | 65193-87-5 | 1050477-31-0 Finerenone Intermediate |
| 4-Cyano-2-metoxibensaldehyd | 21962-45-8 | |
| 4-amino-2-hydroxi-5-metylpyridin | 95306-64-2 | |
| (Z)-2-cyanoetyl-2-(4-cyano-2-metoxibensyliden)-3-oxobutanoat | 1050477-39-8 | |
| Metyl-4-amino-2-metoxibensoat | 27492-84-8 | 857890-39-2 Lenvatinibmesylat Intermediär |
| 4-klor-7-metoxikinolin-6-karboxamid | 417721-36-9 | |
| 4-amino-3-klorfenolhydroklorid | 52671-64-4 | |
| 4-[3-klor-4-(cyklopropylaminokarbonyl)aminofenoxi]-7-metoxi-6-kinolinkarboxamid | 417716-92-8 | |
| 4-amino-3-klorfenol | 17609-80-2 | |
| Fenylväte [(R)-1-(6-amino-9H-purin-9-yl)propan-2-yloxi]metylfosfonat | 379270-35-6 | Tenofovir Alafenamid Fumarate Intermediate |
| Tenofovir alafenamid | 379270-37-8 | |
| 4-(3-fluoro-bensyloxi)-bensaldehyd | 66742-57-2 | Safinamid Mesylate Intermediate |
| Safinamid | 133865-89-1 | |
| (S)-1-(2,6-diklor-3-fluorfenyl)etanol | 877397-65-4 | Crizotinib Intermediate |
| (R)-5-brom-3-(1-(2,6-diklor-3-fluorfenyl)etoxi)pyridin-2-amin | 877399-00-3 | |
| Tert-butyl 4-[4-(4,4,5,5-tetrametyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]piperidin-1-karboxylat | 877399-74-1 | |
| 4-hydroxi-7-fenoxi-3-isokinolinkarboxylsyrametylester | 1455091-10-7 | Roxadustat Intermediate |
| Ortobensoylbensoesyra | 85-52-9 | |
| 2-aminobensofenon | 2835-77-0 | |
| 2-amino-5-bromodibensofenon | 39859-36-4 | |
| Ortobensylanilin | 28059-64-5 | |
| 2-amino-5-klordibensofenon | 719-59-5 | |
| 2-amino-4'-fluorbensofenon | 3800-6-4 | |
| 2-amino-4'-klorbensofenon | 2894-51-1 | |
| 1-amino-2-bensoylnaftalen | 153684-50-5 | |
| 2-amino-5-bromo-2'-fluorobensofenon | 1479-58-9 | |
| 3-metyl-4-metoxikarbonylbensaldehydoxim | 1261169-50-9 | Fluralaner Intermediate |
| 3', 5' - Dikloro-2,2,2-trifluorfenon | 130336-16-2 | |
| 2-amino-N-(2,2,2-trifluoretyl)acetamidhydroklorid | 1171331-39-7 | |
| 2-metyl-4-acetylbensoesyra | 55860-35-0 | |
| 2-cyanofenylboronsyra 1,3-propandiol cyklisk ester | 172732-52-4 | Perampanel Intermediate |
| 2-bensonitril borsyra pinacol ester | 214360-48-2 | |
| 5-(2-pyridyl)-1,2-dihydropyridin-2-on | 381233-78-9 | |
| 1 '- fenyl - [2,3'-bipyridin] -6 '(1'H) - en | 381725-50-4 | |
| Fenylboronsyra | 98-80-6 | |
| 4-(4-aminofenyl)-3-metyl-4-oxosmörsyra | 42075-29-6 | Levosimendan Intermediate |
| 4-(4-aminofenyl)-3-metyl-4-oxobutyrathydroklorid | 120757-13-3 | |
| 4-hydroxipyrrolo[2,3-d]pyrimidin | 3680-71-5 | Tofacitinib och Ruxolitinib Intermediate |
| 4-kloropyrrolidin | 3680-69-1 | |
| (3R, 4R)-N,4-dimetyl-1-(fenylmetyl)-3-piperidin-dihydroklorid | 1062580-52-2 | |
| 4-metyl-7H-pyrrolino[2,3-d]pyrimidin | 945950-37-8 | |
| 2,4-dihydroxipyridin | 626-03-9 | Pyridin Intermediär |
| 2,4-diklor-3-nitropyridin | 5975-12-2 | |
| 2,4-diklorpyridin | 26452-80-2 | |
| 3-amino-2,4-diklorpyridin | 173772-63-9 | |
| 2-amino-5-metoxipyridin | 10167-97-2 | |
| 4-amino-2-klor-3-nitropyridin | 2789-25-5 | |
| 3-klor-4-cyanopyridin | 68325-15-5 | |
| 4-klor-3-nitropyridin | 13091-23-1 | |
| 2,6-difluorfenylboronsyra | 162101-25-9 | |
| 2,6-difluorfenol | 28177-48-2 | |
| 6-klor-1,3-dimetyluracil | 6972-27-6 | |
| 3-nitro-4-kloranilin | 635-22-3 | |
| 5-etoxi-2-merkaptobensimidazol | 55489-15-1 | |
| Metylnitroacetat | 2483-57-0 | |
| 2-brom-3-metylbensonitril | 263159-64-4 | |
| 1-etylpyrazol | 2817-71-2 | |
| 6-bromindol-2-karboxylsyra | 16732-65-3 | |
| Metyl-2-amino-5-hydroxibensoat | 1882-72-0 | |
| 2-bromstearinsyra | 142-94-9 | |
| Klormetylklorsulfonsyraester | 49715-04-0 | |
| 1-tert-butoxikarbonyl-3-hydroxi-pyrazol-4-karboxylsyraetylester | 178424-17-4 | |
| 4-brom-l-metylpyrazol | 15803-02-8 | |
| 1-Acetoxi-2,3,5-tribensoyloxi-1-beta-D-furanribos | 6974-32-9 | |
| 3-nitro-4-klorbensensulfonamid | 1997--9--6 | |
| 1,3-dimetyl-6-aminouracil | 6642-31-5 | |
| (4-cyklopropyl-6-metoxipyrimidin-5-yl)borsyra | 1798304-51-4 | |
| 3-cyklopropyl-3-oxopropionat-metylester | 32249-35-7 | Pitavastatin Kalcium Mellanprodukt |
| 2-cyklopropyl-4-(4-fluorfenyl)-3-kinolinol (pivalol) | 121660-11-5 | |
| [2-cyklopropyl-4-(4-fluorfenyl)-3-kinolinyl] metyl] trifenylfosfinbromid | 154057-58-6 | |
| (4R cis)-6-aldehyd-2,2-dimetyl-1,3-dioxan-4-acetat-tert-butylester (D7) | 124752-23-4 | |
| Pivastatin isopropyl tert butyl ester | 147489-06-3 | |
| 4-(6-aminopyridin-3-yl)piperazin-1-karboxylsyra-tert-butylester | 571188-59-5 | Pabucilib Intermediate |
| 6-brom-2-klor-8-cyklopentyl-5-metyl-pyridino [2,3-D] pyrimidin | 1016636-76-2 | |
| 4-(1,2-bensisotiazol-3-yl)-1-piperazin | 87691-87-0 | Lurasidon HCL Intermediär |
| 4-(1,2-bensisotiazol-3-yl)-1-piperazinhydroklorid | 144010-02-6 | |
| (3AR, 4S, 7R, 7AS) 4,7-metylen-lH-isoindol-1,3 (2H)-dion | 14805-29-9 | |
| (IR, 2R) -1,2-cyklohexandimetanol | 65376-05-8 | |
| 1-(2-kloretyl)azepanhydroklorid | 26487-67-2 | Bazedoxifen Intermediär |
| N-(2-hydroxietyl)hexametylenmin | 20603-00-3 | |
| 2-metyl-2-oxazolin | 1120-64-5 | Nefazodon Intermediär |
| 1-Fenyl-1,2,3,4-tetrahydroisokinolin | 22990-19-8 | Solifenacin Intermediär |
| 6-Bromhexan-2-on | 10226-29-6 | Pentoxifyllin Intermediär |
| Mannos triflate | 92051-23-5 | Prekursor för radiotracer 18FDG för cellmetabolismavbildning |
| 1-(4-klorfenyl)-1-fenyletanol | 59767-24-7 | Clemastine Intermediate |
| 2-(2-kloretyl)-N-metyl-pyrrolidinhydroklorid | 56824-22-7 | |
| 1-Metyl-2-pyrrolidinetanol | 67004-64-2 | Clemastine abd Udenafil Intermediate |
| 2-(2-aminoetyl)-l-metylpy | 51387-90-7 | Chloramidine Intermediate och andra |
| L-hydroxiprolin | 51-35-4 | |
| Echinocandin B | 79411-15-7 | |
| PneumocandinBo | 135575-42-7 | |
| D-glukosaminhydroklorid | 66-84-2 | |
| PYRROLOQUINOLINE KINONDINATRIUMSALT | 122628-50-6 | |
| FR901379 | 144371-88-0 | micafungin Intermediär |
| FR179642 | 168110-44-9 | |
| Ansamitocin P-3 | 66547-09-9 | |
| Calicheamicin | 113440-58-7 | |
| Dactinomycin | 50-76-0 | |
| SAM (S-Adenosy-L-Metionin) | 200393-05-1 | |
| Levulinsyra | 123-76-2 | |
| Etyllevulinat | 539-88-8 | |
| butyl-4-oxopentanoat | 2052-15-5 | |
| Tributylfosfat | 126-73-8 | |
| Triisobutylfosfat | 126-71-6 | |
| trioktylfosfat | 78-42-2 | |
